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β-thalassemia is a group of heterogeneous recessive disorders common in many parts of the world. Al-Qatif and Al-Hassa oases in
the Eastern Province of Saudi Arabia are regions known for high frequency of these disorders. Using two molecular methods, based
on multiplexing-ampliﬁcation refractory system and reverse hybridization principles, the spectrum of β-thalassemia in the region
was studied. Sixty-nine subjects with known β-thalassemia disease and volunteers with high hemoglobin A2(HbA2) and low mean
corpuscular volume (MCV) were included in this study. Ten mutations were detected in 91% of the subjects under study. Six of
these mutations had previously been observed while the other four mutations are reported here for the ﬁrst time. In addition, four
of the mutations accounted for 76.8% of the subjects studied. IVSII-1 (G >A), IVSI-5 (G > A), and codon 39 (C >T) mutations
were found to be the most frequent. However, the frequencies of diﬀerent mutations reported here are slightly diﬀerent from those
reported earlier. A number of these mutations were also found in the neighboring countries, which can be explained in terms of
gene ﬂow.
INTRODUCTION
β-thalassemia is a group of heterogeneous autosomal
recessive disorders due to the absence or reduced syn-
thesis of the β-globin chain [1]. Consequently, the ex-
cess production of α-globin chain leads to its precipita-
tion within the red blood cells causing ineﬀective erythro-
poiesis [2, 3]. Extensive work in the last two decades has
led to the elucidation of the spectrum of these monogenic
disorders [4]. Over 200 diﬀerent mutations leading to β-
thalassemiahavebeencharacterizedworldwide[3].Avar-
ied clinical expression is exhibited by homozygotes and
compound heterozygotes [5]. The majority of these mu-
tations are due to small nucleotide substitutions and dele-
tions [3]. However, the mutations are population speciﬁc,
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and common and rare mutations are found in each popu-
lation [6]. In the Middle East codon 39 (C > T), IVSI-110
(G > A), IVSI-1 (G > A), IVSI-6 (T > C), IVSII-1 (G >
A), codon 5(-CT), and IVSI-5 (G > C) mutations account
for more that 90% of β-thalassemia mutations in the re-
gion [7, 8]. However, these mutations diﬀer in numbers
andfrequenciesbetweendiﬀerentpopulationsoftheMid-
dle East. Over ﬁfty diﬀerent mutations have been identi-
ﬁed in the Arab populations reﬂecting the heterogeneity
of these populations. In order to prevent transmission of
the mutation, carriers of β-thalassemia need to be identi-
ﬁed since their oﬀspring are at risk of inheriting the mu-
tation. Therefore, this work was carried out to study the
spectrum of mutations of β-thalassemia in the Eastern
Province of Saudi Arabia where inherited blood disorders
are common.
METHODS
Over a period of two years, sixty-nine blood samples
were randomly collected from unrelated Saudi male and
female individuals with β-thalassemia attending King Fa-
had Hospital of the University, Al-Khobar, and from vol-
u n t e e r sw i t hH b A 2 > 3% (50 volunteers, 19 patients). Af-
terwritteninformedconsentwasobtained, 3mLofwhole2005:4 (2005) β-Thalassemia Mutations 323
Table 1. β-thalassemia alleles identiﬁed in the population of the Eastern Province of Saudi Arabia.
Mutation Mutation class Origin Allele frequency (%)
IVSII-1 (G > A) Splice site Mediterranean 27.5
IVSI-5 (G > C) Consensus mutation Asian 23.2
Codon 39 (C > T) Nonsense Mediterranean 20.3
IVSI-1 (G > A) Splice junction Mediterranean 5.8
IVSI-6 (T > C) Consensus splice site Mediterranean 4.4
IVSI-25bp Splice junction Asian 4.4
Codon 5(-CT) Frameshift Mediterranean 1.5
Codon 36/37(-T) Frameshift Kurdish/Iranian 1.5
Codon 44-C Frameshift Kurdish 1.5
IVSII-745 (C > G) Consensus splice site Mediterranean 1.5
blood was collected in EDTA-coated tubes. Complete
blood count was determined using Coulter Micro Diﬀ
II machine and HbA2 was determined by aﬃnity chro-
matography. Genomic DNA was extracted from periph-
eral blood leukocytes according to standard procedures
[9]. Mutation detection was carried out by the method of
Fortina et al, which is based on the combination of mul-
tiplexing and ampliﬁcation refractory system [10]. Five
common mutations were screened by four separate re-
actions containing upstream primer and either four nor-
m a lo rf o u rm u t a n tp r i m e r s .P o l y m e r a s ec h a i nr e a c t i o n
(PCR)mixturescontained1µgofgenomicDNA,100mM
Tris HCl (pH 8.3), 50mM KCl, 100µMd N T Pm i x t u r e ,
1.5mMMgCl 2,a n d0 .01%(w/v) gelatin in a total volume
of 50µL. The mixtures were heated for 5minutes at 95◦C
followed by the addition of four units of Taq DNA poly-
merase. Twenty-ﬁve PCR cycles of 95◦C for 1minute and
combined annealing and extension at 66◦Cf o r2m i n u t e s
with the last cycle of 3minutes at 66◦C were carried out.
The β- globin strip Aassay kit was used to conﬁrm the re-
sults obtained by the multiplex PCR method as well as de-
tecting those mutations not covered by the above method
[11]. In this method, PCR ampliﬁcation was carried out
using biotinylated primers, followed by hybridization of
the PCR product to a test strip containing allele-speciﬁc
oligonucleotide probes immobilized as an array of paral-
lel lines. Bound biotinylated sequences were detected us-
ing streptavidin phosphatase and color substrate.
RESULTS AND DISCUSSION
β-thalassemias are severe congenital disorders caused
by mutations in the β-globin gene resulting in the ab-
sence or reduced synthesis of the β-globin chain. This
deﬁcit leads to precipitation of excess α-globin chains
resulting in the formation of inclusion bodies. In ho-
mozygotes and compound heterozygotes, this leads to a
life-long dependency on blood transfusions to maintain
satisfactory levels of hemoglobin along with iron chela-
tion therapy to combat iron overload. Gene frequency
for thalassemia diﬀers markedly among diﬀerent popu-
lations, reaching 10% in certain areas. Over 200 diﬀerent
mutations have been elucidated worldwide. However, in
each population a number of common mutations (usu-
allyabout5–10)existwhichaccountformorethan90%of
all mutations [12]. β-thalassemia is endemic in the Arab
countries including the countries of the Gulf region [8].
In Al-Qatif and Al-Hassa oases in the Eastern Province of
Saudi Arabia, the frequency of hemoglobin S and both β-
and α-thalassemia has been reported to be high [13, 14].
A number of reports have described the type of muta-
tions that are common among the population of this area
[15, 16, 17]. However, in the present study we report ad-
ditional mutations which have not been reported earlier
due to either limited sample size or the limitations of the
procedures used. Ninety percent of all samples included
in this study which had high HbA2 (> 3 % )a n dl o wM C V
(< 70 ft) were shown to be homozygous or heterozygous
for one of the β-thalassemia mutations detected by our
procedures. Ten mutations were identiﬁed in all subjects
studied(Table 1).Sixofthesemutations(IVSII-1(G>A),
codon 39 (C > T), IVSI-5 (G > C), IVSI-25bp, IVSI-1 (G
> A), and codon 44(-C)) have previously been identiﬁed
in the Eastern Province population [15, 16, 17]. Four of
the mutations (codon 5 (-CT), IVSII-745 (G > C), IVSI-
6( T> A), and codon 36/37 (-T)) are reported here for
the ﬁrst time in this population. Four of the mutations
account for 76.8% of subjects studied. IVSII-1 (G > A)
mutation was the most frequently encountered with a fre-
quency of 27.5%. This was followed by IVSI-5 (G > C)
with a frequency of 23.2%, codon 39 (C > T) with a fre-
quency of 20.3%, and IVSI-1 (G > A) with a frequency
of 5.8%. All other detected mutations had a genotype fre-
quency of 4.4% or less.
Most of these mutations are found in neighboring
countrieswithvaryingfrequency.Thisisinlinewithstud-
ies in otherparts of the worldwhichhave shownthatgene
ﬂow due to population migration is common. Although
IVSII-1 (G > A) has been previously reported to have an
allelefrequencyof15.1%,ourstudyindicatesthatinfactit
is the most common mutation (27.5%) in this area [17].
This mutation is also the most common in neighboring
Kuwait at a frequency of 29% [18]. Codon 39 (C > T)
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neighboring Bahrain (24%) has been reported previously
in the Saudi population at a high frequency [17, 18, 19].
Interestingly, the IVSI-5 (G > C) mutation has been re-
ported at a very low frequency of 1.8% for the Eastern
Province population [17] and at a higher frequency of
12% for the country as whole [15], in comparison to
23.2% in the present study. Although it is diﬃcult to
speculate on these discrepancies, it is worth mentioning
that this mutation is the most frequent and widespread
in the neighboring regions. The frequency of IVSI-5 (G
> C) mutation in the Western Province of Saudi Ara-
bia, Bahrain, Kuwait, UAE, and Oman are 22.5%, 16.2%,
18%, 55%, and 62%, respectively [8, 19, 20, 21]. There-
fore, it is not surprising that the IVSI-5 (G > C) mutation
is found at high frequency in the Eastern Province due to
gene ﬂow. Both IVSI-1 (G > A) and IVSI-6 (T > A), which
are Mediterranean in origin, are also found at lower fre-
quencies in the population of the Eastern Province. Al-
though IVSI-25bp mutation is found at high frequency
in neighboring Bahrain (36%), in the population of the
Eastern Province it is only found at low frequency (2.7%).
Codon 44(-C) mutation, which is of Kurdish origin, is
foundintheGulfcountryofOmanandatalowfrequency
in the present population of the Eastern Province. Codon
36/37(-T) which is of Kurdish/Iranian origin and IVSII-
745 (G > C) and IVSI-6 (T > A) which are of Mediter-
raneanoriginarealsofoundinthepresentpopulationbut
at a lower frequency. Therefore, it is not surprising that
such mutations are found in the Eastern Province due to
the close proximity of these populations.
In summary, the present report identiﬁes four new
mutations in the population of the Eastern Province. The
frequenciesofthemutationsreportedinthepresentstudy
are in line with the frequencies of these mutations re-
ported in the surrounding populations.
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